Aveanna: Q3 Earnings Snapshot

Aveanna Healthcare Holdings Inc. (AVAH) reported Q3 profit of $45.5M, or 20 cents per share, beating analyst estimates. Revenue was $695.5M, also exceeding forecasts. Shares have risen 60% YTD and 46% over the past year, according to the company and Zacks Investment Research.

Original reporting
Published Nov 12, 2026, 12:11 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 12, 2026, 12:15 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Aveanna: Q3 Earnings Snapshot — source image
Decision brief

The 30-second read

$AVAHBullishHigh
01

Why it matters

The earnings beat may trigger buying interest and short covering, supporting a price rise.

02

Market read

Fresh earnings data with a beat can drive short-term price movement and influence sector sentiment.

03

What to watch

Potential headwinds from regulatory changes in home health care could temper upside.

Relevance 8/10Novelty 8/10Timing: after-hours release

Background

Aveanna Healthcare Holdings Inc. (AVAH) is a provider of home health care services listed on NASDAQ.

Company-level read

Ticker impact

$AVAHBullishHigh confidence
Context

Aveanna Healthcare reported Q3 profit of $45.5M, EPS 20¢ and revenue $695.5M, both beating Zacks estimates.

Expected impact

likely upward as market prices in the earnings beat

Evidence & confidence

The company posted better-than-expected earnings and revenue, a fresh primary disclosure that can move the share price.

Market effects

Home health care sector may see broader positive sentiment from the beat.

U.S. healthcare stocks could benefit in the near term.

Limited to U.S. listed healthcare equities.

Counterpoint

If the beat is already priced in, the stock could face a short-term pullback.

Key entities

  • Aveanna Healthcare Holdings Inc.

    Home health care services provider reporting Q3 results.

Related articles

$AVAHHighAI 8/10

Aveanna Healthcare Earnings Call Signals Broader Growth, Higher Guidance

Aveanna Healthcare (AVAH) reported Q3 revenue of $695.5M, up 11.8%, and adjusted EBITDA of $100.1M, up 25%. All segments grew, with Home Health and Hospice up 15.6%, Private Duty Services up 11.6%, and Medical Solutions up 9.1%. The company raised 2026 guidance to revenue above $2.695B and adjusted EBITDA above $374M, citing growth in preferred payers and state rate enhancements. Management highlighted caregiver shortages and California rate uncertainty as risks.

$AVAHMedAI 8/10

What Aveanna Healthcare (AVAH) Said on Its Q3 Earnings Call

Aveanna Healthcare (AVAH) reported Q3 revenue growth of 15.6% to $72.1M in Home Health and Hospice, and 9.1% to $49.2M in Medical Solutions. CEO Shaner cautioned that 20-25% growth is unsustainable. The company secured $30M in California funding for rate increases, aiming for permanency. Aveanna reconfirmed long-term growth targets and plans to focus acquisitions on Home Health and Hospice. It reported $492M in liquidity and $1.52B in variable-rate debt, all hedged through 2029.

$AVAHHigh

Raymond James reiterates Strong Buy on Aveanna stock after beat

Raymond James reiterated a Strong Buy rating and $15.00 price target for Aveanna Healthcare (AVAH) after its Q3 2026 results beat estimates. AVAH reported adjusted EBITDA of $100.1M, 7.5% above consensus, and raised its 2026 EBITDA guidance to at least $374M. The stock trades at $13.09, with 13% upside to the target. RBC Capital increased its price target to $16.00, citing positive market positioning.